| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Short-term investments in marketable securities | - | 8,996 | ||
| Cash and cash equivalents | 56,312 | 62,671 | ||
| Prepaid expenses and other current assets | 4,927 | 4,208 | ||
| Total current assets | 61,239 | 75,875 | ||
| Total property and equipment | 68,323 | - | ||
| Less accumulated depreciation and amortization | 38,883 | - | ||
| Property and equipment, net | 29,440 | 31,285 | ||
| Operating lease right-of-use assets | 10,057 | 10,682 | ||
| Other noncurrent assets | 4,244 | 4,309 | ||
| Total assets | 104,980 | 122,151 | ||
| Accounts payable | 2,843 | 3,297 | ||
| Accrued and other current liabilities | 7,441 | 6,523 | ||
| Operating lease liabilities, current | 2,926 | 2,834 | ||
| Total current liabilities | 13,210 | 12,654 | ||
| Operating lease liabilities, noncurrent | 8,601 | 9,376 | ||
| Other noncurrent liabilities | 301 | 293 | ||
| Total liabilities | 22,112 | 22,323 | ||
| Common stock | 16 | 16 | ||
| Additional paid-in capital | 667,685 | 664,371 | ||
| Accumulated other comprehensive income (loss) | - | -1 | ||
| Accumulated deficit | -584,833 | -564,558 | ||
| Total stockholders' equity | 82,868 | 99,828 | ||
| Total liabilities and stockholders' equity | 104,980 | 122,151 | ||
Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc. (TNYA)